Dr. Tanuja A. Bhandari, MD

Dr. Bhandari practices at Providence St. Joseph Hospital Orange in Orange, California, part of Providence Health & Services.

Dr. Bhandari's NPI, 1518147610, was assigned on November 6, 2007. Dr. Bhandari graduated from American University of the Caribbean School of Medicine in 2001. Dr. Bhandari holds California license A101871.

Dr. Bhandari's primary practice is Providence St. Joseph Hospital Orange, at 1100 West Stewart Dr, Orange, CA 92868 in Orange County. The practice phone is (714) 633-9111.

Dr. Bhandari's primary practice is Providence St. Joseph Hospital Orange in Orange, California, part of Providence Health & Services. The medical group on file is City of Hope. Dmand AI also links Dr. Bhandari to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhandari practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Bhandari's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Bhandari is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Bhandari's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists anal cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cervical cancer radiation, colorectal cancer radiation and head & neck cancer radiation among the conditions Dr. Bhandari treats.

CMS data shows 808 Medicare services from Dr. Bhandari across 13 procedure codes in 2024, for 103 Medicare patients. Medicare paid $71,960 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 103 Medicare patients who saw Dr. Bhandari in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have cancer, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhandari's median patient age at 67, with 82% women.

In 2024, Dr. Bhandari wrote 67 Medicare Part D claims for 44 patients. 69% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $230 in total drug cost. In 2023, CMS named 38 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Bhandari for performance year 2024, reported as part of a group. Dr. Bhandari accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Bhandari, published from 2008 to 2019. The most frequent topics are Breast Neoplasms, Mastectomy, Segmental and Brachytherapy. Dr. Bhandari has published most often in Brachytherapy. Dr. Bhandari's most frequent co-authors are Robert Blair Ash, MD, Maher Gobran, MD and Jay K. Harness, MD.

CMS Open Payments shows 55 general payments to Dr. Bhandari from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $565.

Dr. Bhandari graduated from American University of the Caribbean School of Medicine in 2001.

Dr. Bhandari is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.